Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy.

Thakur V, Sadanandan J, Chattopadhyay M.

Int J Mol Sci. 2020 Jan 30;21(3). pii: E881. doi: 10.3390/ijms21030881.

2.

RETRACTED: Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes.

Galloway C, Chattopadhyay M.

Cytokine. 2018 Oct;110:483. doi: 10.1016/j.cyto.2018.03.015. No abstract available.

PMID:
30126731
3.

The Efficacy of Graphene Foams for Culturing Mesenchymal Stem Cells and Their Differentiation into Dopaminergic Neurons.

Tasnim N, Thakur V, Chattopadhyay M, Joddar B.

Stem Cells Int. 2018 Jun 3;2018:3410168. doi: 10.1155/2018/3410168. eCollection 2018.

4.

The applicability of furfuryl-gelatin as a novel bioink for tissue engineering applications.

AnilKumar S, Allen SC, Tasnim N, Akter T, Park S, Kumar A, Chattopadhyay M, Ito Y, Suggs LJ, Joddar B.

J Biomed Mater Res B Appl Biomater. 2019 Feb;107(2):314-323. doi: 10.1002/jbm.b.34123. Epub 2018 Apr 15.

5.

Early Urinary Markers for Diabetic and Other Kidney Diseases.

Thakur V, Chattopadhyay M.

Curr Drug Targets. 2018;19(7):825-831. doi: 10.2174/1389450119666180319124639. Review.

PMID:
29552988
6.

Delivery of Mesenchymal Stem Cells from Gelatin-Alginate Hydrogels to Stomach Lumen for Treatment of Gastroparesis.

Joddar B, Tasnim N, Thakur V, Kumar A, McCallum RW, Chattopadhyay M.

Bioengineering (Basel). 2018 Feb 7;5(1). pii: E12. doi: 10.3390/bioengineering5010012.

7.

Role of Glycyrrhizin in the Reduction of Inflammation in Diabetic Kidney Disease.

Thakur V, Nargis S, Gonzalez M, Pradhan S, Terreros D, Chattopadhyay M.

Nephron. 2017;137(2):137-147. doi: 10.1159/000477820. Epub 2017 Jun 23.

PMID:
28641285
8.

Effect of exercise on neurogenic inflammation in spinal cord of Type 1 diabetic rats.

Thakur V, Gonzalez M, Pennington K, Nargis S, Chattopadhyay M.

Brain Res. 2016 Jul 1;1642:87-94. doi: 10.1016/j.brainres.2016.03.012. Epub 2016 Mar 24.

PMID:
27018295
9.

Viral vector mediated continuous expression of interleukin-10 in DRG alleviates pain in type 1 diabetic animals.

Thakur V, Gonzalez M, Pennington K, Chattopadhyay M.

Mol Cell Neurosci. 2016 Apr;72:46-53. doi: 10.1016/j.mcn.2016.01.006. Epub 2016 Jan 21.

PMID:
26802537
10.

Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review).

Subramani R, Gangwani L, Nandy SB, Arumugam A, Chattopadhyay M, Lakshmanaswamy R.

Int J Oncol. 2015 Oct;47(4):1203-10. doi: 10.3892/ijo.2015.3129. Epub 2015 Aug 21. Review.

11.

Moderate exercise training attenuates inflammatory mediators in DRG of Type 1 diabetic rats.

Yoon H, Thakur V, Isham D, Fayad M, Chattopadhyay M.

Exp Neurol. 2015 May;267:107-14. doi: 10.1016/j.expneurol.2015.03.006. Epub 2015 Mar 14.

PMID:
25783659
12.

Decrease in neuroimmune activation by HSV-mediated gene transfer of TNF╬▒ soluble receptor alleviates pain in rats with diabetic neuropathy.

Ortmann KL, Chattopadhyay M.

Brain Behav Immun. 2014 Oct;41:144-51. doi: 10.1016/j.bbi.2014.05.009. Epub 2014 May 29.

13.
14.

RETRACTED: Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes.

Galloway C, Chattopadhyay M.

Cytokine. 2013 Jul;63(1):1-5. doi: 10.1016/j.cyto.2013.04.009. Epub 2013 May 8. Erratum in: Cytokine. 2018 Oct;110:483.

PMID:
23664770
15.

Reduction of voltage gated sodium channel protein in DRG by vector mediated miRNA reduces pain in rats with painful diabetic neuropathy.

Chattopadhyay M, Zhou Z, Hao S, Mata M, Fink DJ.

Mol Pain. 2012 Mar 22;8:17. doi: 10.1186/1744-8069-8-17.

16.

Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neurons.

Chattopadhyay M, Mata M, Fink DJ.

Eur J Pain. 2011 Oct;15(9):913-20. doi: 10.1016/j.ejpain.2011.03.007. Epub 2011 Apr 12.

17.

Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons.

Chattopadhyay M, Walter C, Mata M, Fink DJ.

Brain. 2009 Apr;132(Pt 4):879-88. doi: 10.1093/brain/awp014. Epub 2009 Feb 24.

18.

Gene therapy for the treatment of diabetic neuropathy.

Mata M, Chattopadhyay M, Fink DJ.

Curr Diab Rep. 2008 Dec;8(6):431-6. Review.

19.
20.

Gene therapy for the treatment of sensory neuropathy.

Mata M, Chattopadhyay M, Fink DJ.

Expert Opin Biol Ther. 2006 May;6(5):499-507. Review.

PMID:
16610979

Supplemental Content

Loading ...
Support Center